Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/10/21 EDT
70.70quote price arrow down-0.29 (-0.41%)
Volume
227,924
Close
70.99quote price arrow up+0.38 (+0.54%)
Volume
4,845,416
52 week range
56.56 - 73.34
Loading...
  • Open70.98
  • Day High71.44
  • Day Low70.25
  • Prev Close70.61
  • 52 Week High73.34
  • 52 Week High Date08/18/21
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap89.008B
  • Shares Out1.254B
  • 10 Day Average Volume5.93M
  • Dividend2.84
  • Dividend Yield4.00%
  • Beta0.42
  • YTD % Change21.85

KEY STATS

  • Open70.98
  • Day High71.44
  • Day Low70.25
  • Prev Close70.61
  • 52 Week High73.34
  • 52 Week High Date08/18/21
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap89.008B
  • Shares Out1.254B
  • 10 Day Average Volume5.93M
  • Dividend2.84
  • Dividend Yield4.00%
  • Beta0.42
  • YTD % Change21.85

RATIOS/PROFITABILITY

  • EPS (TTM)4.07
  • P/E (TTM)17.42
  • Fwd P/E (NTM)10.65
  • EBITDA (MRQ)11.692B
  • ROE (MRQ)27.36%
  • Revenue (MRQ)26.638B
  • Gross Margin (MRQ)80.14%
  • Net Margin (MRQ)19.28%
  • Debt To Equity (MRQ)153.15%

EVENTS

  • Earnings Date10/26/2021
  • Ex Div Date09/14/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

Profile

MORE
Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company's portfolio of products and pipeline of investigational drugs includes treatments for HIV/acquired immune deficiency syndrome (AIDS), COVID-19, liver diseases, hematology/oncology/cell therapy and other. Its products for HIV/AIDS patients include Biktarvy, Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Flavius Martin M.D.
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
AMGN
Amgen Inc
213.75-1.83-0.85%
ZTS
Zoetis Inc
207.00+0.98+0.48%
GSK
GlaxoSmithKline PLC
39.75-0.03-0.08%
AZN
AstraZeneca PLC
56.26-0.03-0.05%
SNY
Sanofi SA
48.32-0.74-1.51%